Home › Markets › Health Care › VMD

Viemed Healthcare Inc. Common Shares (VMD)

VMD trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$9.61
+0.10% on the day
Market cap
$366.0M
Small cap
Revenue · 2025
$270.3M
+20.5% on 2024
Net income · 2025
$15.4M
5.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerVMD on Nasdaq
SectorHealth Care
IndustryMisc Health and Biotechnology Services
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001729149
SEC industry codeServices-Misc Health & Allied Services, NEC
Incorporated inA1

Financials · 2025

LineValue
Revenue$270.3M
Net income$15.4M
Operating income$22.9M
Net margin5.7%
Operating margin8.5%
Revenue growth+20.5%
Cash$13.5M
Total assets$199.2M
P/E (computed)23.8×
P/S (computed)1.4×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3
S-32023-08-24
Latest annual report10-K2026-03-04
Latest quarterly / interim10-Q2026-08-03
Latest current report8-K2026-08-20
Latest proxyDEF 14A2026-04-22

Source: SEC EDGAR submissions feed, 417 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.2%
1 month+10.5%
3 months-20.0%
Year to date+30.1%
1 year+40.6%
From 52-week high-21.6%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Misc Health and Biotechnology Services

TickerCompanyPriceDayMarket cap
PARKPark Dental Partners Inc.$19.59-3.31%$93.2M
AGLagilon health inc.$85.90+0.48%$1.4B
PGNYProgyny Inc.$27.39-2.28%$2.1B
CCELCryo-Cell International Inc.$4.30-4.44%$34.7M
SHCSotera Health Company$18.21+0.33%$5.2B
DVADaVita Inc.$182.08+0.17%$11.6B
FMSFresenius Medical Care AG$21.08-0.61%$11.8B
MGRXMangoceuticals Inc.$0.3716-3.08%$8.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier